 Transcription Factors
"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 5 | 0 | 5 | | 1989 | 1 | 1 | 2 | | 1990 | 5 | 2 | 7 | | 1991 | 4 | 1 | 5 | | 1992 | 4 | 3 | 7 | | 1993 | 9 | 4 | 13 | | 1994 | 13 | 5 | 18 | | 1995 | 18 | 9 | 27 | | 1996 | 12 | 6 | 18 | | 1997 | 16 | 8 | 24 | | 1998 | 24 | 11 | 35 | | 1999 | 23 | 5 | 28 | | 2000 | 35 | 20 | 55 | | 2001 | 30 | 15 | 45 | | 2002 | 55 | 23 | 78 | | 2003 | 40 | 18 | 58 | | 2004 | 39 | 22 | 61 | | 2005 | 33 | 31 | 64 | | 2006 | 14 | 21 | 35 | | 2007 | 13 | 10 | 23 | | 2008 | 18 | 27 | 45 | | 2009 | 25 | 19 | 44 | | 2010 | 20 | 29 | 49 | | 2011 | 29 | 18 | 47 | | 2012 | 21 | 29 | 50 | | 2013 | 31 | 27 | 58 | | 2014 | 25 | 23 | 48 | | 2015 | 24 | 27 | 51 | | 2016 | 16 | 14 | 30 | | 2017 | 10 | 18 | 28 | | 2018 | 18 | 18 | 36 | | 2019 | 10 | 7 | 17 | | 2020 | 17 | 12 | 29 | | 2021 | 15 | 14 | 29 | | 2022 | 3 | 8 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
Kimura S, Montefiori L, Iacobucci I, Zhao Y, Gao Q, Paietta EM, Haferlach C, Laird AD, Mead PE, Gu Z, Stock W, Litzow M, Rowe JM, Luger SM, Hunger SP, Ryland GL, Schmidt B, Ekert PG, Oshlack A, Grimmond SM, Rehn J, Breen J, Yeung D, White DL, Aldoss I, Jabbour EJ, Pui CH, Meggendorfer M, Walter W, Kern W, Haferlach T, Brady S, Zhang J, Roberts KG, Blombery P, Mullighan CG. Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. Blood. 2022 Jun 16; 139(24):3519-3531.
-
French CA, Cheng ML, Hanna GJ, DuBois SG, Chau NG, Hann CL, Storck S, Salgia R, Trucco M, Tseng J, Stathis A, Piekarz R, Lauer UM, Massard C, Bennett K, Coker S, Tontsch-Grunt U, Sos ML, Liao S, Wu CJ, Polyak K, Piha-Paul SA, Shapiro GI. Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 Jun 13; 28(12):2493-2505.
-
Sinha T, Lammerts van Bueren K, Dickel DE, Zlatanova I, Thomas R, Lizama CO, Xu SM, Zovein AC, Ikegami K, Moskowitz IP, Pollard KS, Pennacchio LA, Black BL. Differential Etv2 threshold requirement for endothelial and erythropoietic development. Cell Rep. 2022 May 31; 39(9):110881.
-
Ishi Y, Zhang Y, Zhang A, Sasaki T, Piunti A, Suri A, Watanabe J, Abe K, He X, Katagi H, Bhalla P, Natsumeda M, Zou L, Shilatifard A, Hashizume R. Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors. Mol Cancer Ther. 2022 May 04; 21(5):715-726.
-
Parriott G, Kee BL. E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia. Front Immunol. 2022; 13:885144.
-
Catela C, Chen Y, Weng Y, Wen K, Kratsios P. Control of spinal motor neuron terminal differentiation through sustained Hoxc8 gene activity. Elife. 2022 03 22; 11.
-
Carr T, McGregor S, Dias S, Verykokakis M, Le Beau MM, Xue HH, Sigvardsson M, Bartom ET, Kee BL. Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia. Front Immunol. 2022; 13:845488.
-
Stormo AED, Shavarebi F, FitzGibbon M, Earley EM, Ahrendt H, Lum LS, Verschueren E, Swaney DL, Skibinski G, Ravisankar A, van Haren J, Davis EJ, Johnson JR, Von Dollen J, Balen C, Porath J, Crosio C, Mirescu C, Iaccarino C, Dauer WT, Nichols RJ, Wittmann T, Cox TC, Finkbeiner S, Krogan NJ, Oakes SA, Hiniker A. The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity. J Cell Biol. 2022 04 04; 221(4).
-
Jotte MRM, McNerney ME. The significance of CUX1 and chromosome 7 in myeloid malignancies. Curr Opin Hematol. 2022 03 01; 29(2):92-102.
-
Sharma AE, Pytel P, Cipriani NA. SOX9 and SATB2 immunohistochemistry cannot reliably distinguish between osteosarcoma and chondrosarcoma on biopsy material. Hum Pathol. 2022 03; 121:56-64.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|